CEBPG

Aliases
  • C/EBP gamma
  • CCAAT/enhancer binding protein (C/EBP), gamma
  • CCAAT/enhancer-binding protein gamma
  • CEBPG
  • GPE1BP
  • IG/EBP-1
  • c/EBP gamma
Description
The CEBPG protein is a transcription factor that binds to the enhancer element PRE-I (positive regulatory element-I) of the IL-4 gene.. The C/EBP family of transcription factors regulate viral and cellular CCAAT/enhancer element-mediated transcription. This family includes several related proteins: C/EBP alpha, C/EBP beta, C/EBP gamma, and C/EBP delta, that form homodimers and that form heterodimers with each other. There are two transcript variants that encode the same protein.
Attributes
QA State
Under Review
Type
Gene
HGNC Name
CEBPG
Certifications
  • None
QA State for Lung
Under Review

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.

 Non-Public Biomarker

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.